£2.5M
The seed round was backed by 24Haymarket and Forward Partners alongside existing investors.

24Haymarket is a private capital firm focused on early stage venture and growth equity investments in the UK.
The seed round was backed by 24Haymarket and Forward Partners alongside existing investors.
The investment was led by 24Haymarket to fund upcoming trials for the company IL-6 product.
"We are delighted to announce this funding round led by 24 Haymarket. It shows great confidence in our technology and business plan, and will enable us to kick-on in this particularly exciting phase for MediSieve."
The financing round was led by The Westly Group to support international expansion and ongoing platform innovation.
"We are on a mission to make the world's most complex industrial supply chains more transparent, and help prevent the exploitation of people and our planet. Traceability-as-a-Service is fast becoming a requirement for the world's leading brands and this funding will help us accelerate our impact and revenue growth."
The financing brings total Series A funds to $33m to advance the company cell reprogramming pipeline.
"We are delighted to see the continued support of our existing investors, as well as welcome new investors Astellas Venture Management and Dr Jonathan Milner, in support of the progression of our initial programs through to IND-enabling studies."
The seed follow-on round was co-led by 24Haymarket and Mercia to expand market reach.
"Our technology provided the perfect way to facilitate secure home-working for key organisations at a critical time using our ‘Gatekeeper for Office 365’ remote working solution. Since then, we have applied the same concepts and technology to protect numerous other applications for large organisations, from remote working solutions to securing cloud computing and handling highly sensitive information."